A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

Name: A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
License: Public Domain

Bristol-Myers Squibb

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 329535
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.